Pactiv Evergreen Inc. (PTVE) Tops Q3 EPS by 14c, provides guidance

Pactiv Evergreen Inc. (NASDAQ: PTVE) reported Q3 EPS of $0.32, $0.14 better than the analyst estimate of $0.18. Revenue for the quarter came in at $1.38 billion versus the consensus estimate of $1.39 billion.

Guidance:
Full year 2023 Adjusted EBITDA guidance to a range of $825 million to $835 million

For earnings history and earnings-related data on Pactiv Evergreen Inc. (PTVE) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79